Clinical Scorecard: Left bundle-branch pacing linked to 59% lower risk of composite outcome than right ventricular pacing
At a Glance
| Category | Detail |
|---|---|
| Condition | Atrioventricular block or atrial fibrillation with a slow ventricular response requiring permanent pacing |
| Key Mechanisms | Left bundle-branch pacing activates the native electrical conduction system to promote coordinated ventricular contraction; conventional right ventricular pacing can disrupt ventricular synchrony. |
| Target Population | Adults with second-degree or complete atrioventricular block, or atrial fibrillation with a slow ventricular response, expected to require ventricular pacing at least 20% of the time. |
| Care Setting | Permanent pacemaker implantation; evidence comes from a randomized trial conducted at 17 centers in five countries. |
Key Highlights
- In the modified intention-to-treat analysis of 685 patients, the composite of death, heart failure hospitalization, or pacing-induced cardiomyopathy occurred in 16 patients assigned to left bundle-branch pacing and 35 assigned to right ventricular pacing.
- Estimated 4-year cumulative incidence of the composite outcome was 8.5% with left bundle-branch pacing and 19.2% with right ventricular pacing.
- Pacing-induced cardiomyopathy occurred in 0 patients assigned to left bundle-branch pacing and 19 assigned to right ventricular pacing; estimated 4-year incidence was 0% versus 11.7%.
- All-cause mortality was similar between groups, and procedure-related complications occurred in 3.8% with left bundle-branch pacing and 3.2% with right ventricular pacing.
- The trial met its prespecified superiority threshold and was stopped early on the recommendation of an independent monitoring committee; investigators cautioned that early termination could overestimate treatment benefits.
Guideline-Based Recommendations
Diagnosis
Management
- The trial compared left bundle-branch pacing with conventional right ventricular pacing in patients requiring permanent pacemakers; the source does not provide a clinical guideline recommendation to select one approach.
Monitoring & Follow-up
Risks
- Early trial termination could overestimate the treatment benefit.
- Most participants had preserved left ventricular ejection fraction, limiting generalizability to patients with reduced ejection fraction.
- All left bundle-branch procedures used the same lead type; outcomes with other pacing devices remain uncertain.
Patient & Prescribing Data
The modified intention-to-treat population included 685 adults (mean age 68.4 years; 57.5% men) with qualifying conduction disorders and an expected ventricular pacing burden of at least 20%; most had preserved left ventricular ejection fraction.
At median follow-up of 35.1 months, fewer composite outcome events occurred in the left bundle-branch pacing group than in the right ventricular pacing group. All-cause mortality was similar; procedure-related complications occurred in 3.8% and 3.2%, respectively.
Clinical Best Practices
- The investigators cautioned that early trial termination could overestimate treatment benefits.
- Most participants had preserved ventricular function, limiting generalizability to patients with reduced ejection fraction.
- All left bundle-branch procedures used the same lead type; outcomes with other pacing devices remain uncertain.
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
